1. rjsllewellyn
2. karinkaz
1.karinkaz 03/30/2018
Reata Announces That Kyowa Hakko Kirin Received SAKIGAKE Priority Review Designation for Bardoxolone Methyl in Japan
2.rjsllewellyn 02/28/2018
Reata Provides Program Update on Phase 2 Rare Renal Clinical Trials
3.karinkaz 02/12/2018
long-term follow up
4.rjsllewellyn 03/22/2018
Announces positive top-line data from the Phase 2 LARIAT trial evaluating bardoxolone methyl for the treatme…
5.rjsllewellyn 02/13/2018
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years in PAH Patients From LARIAT Trial
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW